OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms
Mohaddeseh Sadat Alavi, Gholamreza Karimi, Hussein A. Ghanimi, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175726-175726
Closed Access | Times Cited: 13

Showing 13 citing articles:

Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
Pradeepraj Durairaj, Zixiang Liu
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 44-44
Open Access | Times Cited: 1

The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
Mohsen Karbasi Yazdi, Mohaddeseh Sadat Alavi, Ali Roohbakhsh
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 423-438
Open Access | Times Cited: 6

Dynamic Proteome Changes in Cuprizone-Induced Demyelination and Remyelination in the Mouse Brain
Rong-Fang Gu, Xiaoping Hronowski, Zhaohui Shao, et al.
Journal of Proteome Research (2025)
Closed Access

Cholesterol-modifying strategies for alzheimer disease: promise or fallacy?
Katia Azarfar, Boris Decourt, Bernardo León Camacho, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access

The role of the ATP-Binding Cassette A1 (ABCA1) in neurological disorders: a mechanistic review
Tahere Paseban, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 7, pp. 531-552
Closed Access | Times Cited: 9

Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz
Natalia Mast, Makaya Butts, Irina A. Pikuleva
Journal of Lipid Research (2024) Vol. 65, Iss. 6, pp. 100555-100555
Open Access | Times Cited: 3

Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme Cyp46a1 on Behavior and Hippocampal Transcription in Mouse
Hong‐Jin Shu, Luke H. Ziolkowski, Sofia V. Salvatore, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 254-254
Open Access | Times Cited: 2

Calycosin-7-O-β-D-Glucoside Ameliorates Palmitate-Induced Lipid Accumulation in HT22 Cells
Yanming Xu, Dalong Li, Xue Ao, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 5, pp. 641-652
Open Access | Times Cited: 2

Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics
Ben Boyarko, Sonia Podvin, Barry Greenberg, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 10, pp. 2924-2935
Open Access

The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease
Domenico Tripodi, Federica Vitarelli, Simona Spiti, et al.
Advances in experimental medicine and biology (2023), pp. 337-351
Closed Access | Times Cited: 1

Page 1

Scroll to top